We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Baxter International Inc. and other drug companies sold blood-clotting medicine
for hemophiliacs that carried a high risk of transmitting AIDS to markets in
Europe more than a year after switching to newer, safer products in the United
States, according to a lawsuit filed Friday.
Geron Corp. sold $4 million worth of stock and warrants to prominent Hong Kong
investors to fund Geron's financial commitment to TA Therapeutics Ltd. TA Therapeutics
is 50 percent owned by Geron and 50 percent owned by its research partner Biotechnology
Research Corp. and is developing drugs to restore cells that have been affected
by senescence, injury or chronic disease.
TheraCIM h-R3, a humanized monoclonal antibody, received the certificate of
first-category drug granted by the State Food and Drug Administration of China,
for its production and commercialization in that Asian nation.
The Food and Drugs Board (FDB) on Friday directed all clinics and companies
holding stocks of 50 mg artesunate tablets with logos of "Sunflower"
and "Lever" manufactured by Adams Pharmaceutical Group Company Limited
of China to return them to the suppliers.
Bentley Pharmaceuticals, a technology-based specialty pharmaceutical and drug
delivery company with a growing branded and generic product line in Europe,
today announced that it has entered into an agreement with Dong Sung Pharm.
British companies have been
involved in the diversion of cut-price AIDS drugs intended for people in poor
countries, some of which have been sold at a profit to the NHS, it emerged recently.
South African mining firm AngloGold Ashanti, reportedly the country's largest
company, has claimed that only 27% of its 2,700 employees requiring treatment
for HIV/AIDS-related conditions are receiving the antiretroviral (ARV) drugs
that the company distributes free of charge.
According to local studies, a recent officially mandated price
increase on prescription drugs has failed to take effect across much of Brazil's
retail sector.
A Philippines drug industry association, the Pharmaceutical and Healthcare
Association (PHAP), has criticised the government's apparent failure to implement
the Generics Act, a measure originally approved in 1988.
BRAC will extend healthcare facilities to the ultra-poor of the country for
the second consecutive year with the medicines and other supports provided by
Novartis (Bangladesh) Ltd, a global pharmaceutical company.